 | • レポートコード：B-MOR-08389 • 出版社/出版日：Mordor Intelligence / 2018年5月1日 • レポート形態：英文、PDF、112ページ • 納品方法：Eメール（受注後2営業日） • 産業分類：Healthcare |
| Single User（1名様用） | ￥629,000 (USD4,250) | ▷ お問い合わせ |
| Team User（7名様用） | ￥666,000 (USD4,500) | ▷ お問い合わせ |
| Corporate User | ￥1,295,000 (USD8,750) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本資料は、神経系医療装置の世界市場について調べ、神経系医療装置の世界規模、市場動向、市場環境、装置の種類別（脳脊髄液管理装置、ニューロインターベンション用装置、神経内視鏡、脊髄刺激装置、その他）分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、日本市場規模、中国市場規模、企業の競争環境、関連企業情報などをまとめた調査レポートです。 ・イントロダクション ・エグゼクティブサマリー ・神経系医療装置の世界市場インサイト ・神経系医療装置の世界市場環境 ・神経系医療装置の世界市場動向 ・神経系医療装置の世界市場規模 ・神経系医療装置の世界市場規模：装置の種類別（脳脊髄液管理装置、ニューロインターベンション用装置、神経内視鏡、脊髄刺激装置、その他） ・神経系医療装置の世界市場：地域別市場規模・分析 ・神経系医療装置の北米市場規模・予測 ・神経系医療装置のアメリカ市場規模・予測 ・神経系医療装置のヨーロッパ市場規模・予測 ・神経系医療装置のアジア市場規模・予測 ・神経系医療装置の日本市場規模・予測 ・神経系医療装置の中国市場規模・予測 ・神経系医療装置のインド市場規模・予測 ・神経系医療装置の韓国市場規模・予測 ・関連企業情報・競争状況 |
The market for the global neurology devices is expected to witness a CAGR of around 13.5%. The increase in the prevalence of cerebral stroke and other severe disorders such as Alzheimer’s disease, epilepsy, and Parkinson’s is expected to fuel the demand for neurology devices thereby driving the industry.
Increase in Incidence of Neurological Disorders
According to the National Center for Health Statistics of the Centers for Disease Control and Prevention (CDC), 84,767 people died due to Alzheimer’s in 2013. Nearly 80% of the people with epilepsy live in low and middle-income countries, and individuals with epilepsy respond to treatment approximately 70% of the time. Approximately 50 million people worldwide have epilepsy, making it one of the most common neurological diseases globally. In high-income countries, annual new cases are between 30 and 50 per 100,000 people in the general population, and in low- and middle-income countries, this figure can be up to two times higher. Hence, the increasing prevalence of neurological disorders is creating a demand for the early diagnosis of these diseases.
The other factors include, huge investments made by private players in neurology devices, increase in research & development in the field of Neurotherapy and the rise in the number of the aging population.
Stringent FDA Validation and Guidelines for New Devices
Due to the stringent regulations, the approval of the medical devices by the Food and Drug Administration (FDA) depends upon the Class. The majority of the neurological devices have been classified under class II and class III. Class II devices include neurostimulators, aneurysm clips, etc., and Class III devices include deep brain stimulators and medical devices for the treatment of brain tumors. The approval of class III medical devices is complicated and may take 36 months or more depending on the extent of clinical trials. The delay in regulatory approvals is a major challenge faced by the companies involved in the manufacture of neurological devices and is likely to hinder the market of the neurological devices. The high cost of equipment is also one of the restraining factors in the market.
North America Dominates the Market
North America dominates the market and is expected to hold the largest market share due to the significant adoption of neurovascular devices among neurosurgeons, favorable reimbursement scenario, high presence of device manufacturers in the region, and availability of important R&D investments. Asia-Pacific is also expected to witness a lucrative growth due to the growing medical expenditures in the emerging economies, such as India and China.
Key Developments in the Market
• December 2017: Boston Scientific received US FDA approval for the Vercise Deep Brain Stimulation System.
• June 2016: Terumo Corporation entered into an agreement to purchase Sequent Medical.
Major players- B. BRAUN MELSUNGEN AG, BOSTON SCIENTIFIC, STRYKER CORPORATION, MEDTRONIC, INC., ST. JUDE MEDICAL, COVIDIEN PLC, SEQUENT MEDICAL, AND NIHON KOHDEN, amongst others.
Reasons to Purchase the Report
• Follow the current and future neurology devices market in the developed and emerging markets
• Examining the various perspectives of the market with the help of Porter’s Five Forces Analysis
• Identify the segment that is expected to dominate the market
• Identify the regions that are expected to witness the fastest growth during the forecast period
• Identify the latest developments, market shares, and strategies employed by the major market players
• 3 months analyst support along with the Market Estimate sheet (in Excel)
Customization of the Report
• This report can be customized to meet your requirements. Please connect with our analyst, who will ensure you get a report that suits your needs.
レポート目次1. Introduction
1.1 Market Definition
2. Research Methodology
3. Executive Summary
4. Key Inferences
5. Market Overview
5.1 Current Market Scenario
5.2 Porter’s Five Forces Analysis
5.2.1 Bargaining Power of Suppliers
5.2.2 Bargaining Power of Consumers
5.2.3 Threat of New Entrants
5.2.4 Threat of Substitute Products and Services
5.2.5 Competitive Rivalry within the Industry
6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
6.1 Drivers
6.1.1 Increase in Incidence of Neurological Disorders
6.1.2 Huge Investments by Private Players in Neurology Devices
6.1.3 Increase in Research & Development in the Field of Neurotherapies
6.1.4 Rise in the Number of Aging Population
6.2 Restraints
6.2.1 High Cost of Equipment
6.2.2 Stringent FDA Validation and Guidelines for New Devices
6.3 Opportunities
6.4 Key Challenges
7. Market Segmentation
7.1 By Type of Device
7.1.1 Cerebrospinal Fluid Management Devices
7.1.2 Interventional Neurology Devices
7.1.2.1 Neurothrombectomy Devices
7.1.2.2 Carotid Artery Stents
7.1.2.3 Embolic Coils
7.1.2.4 Neurosurgery Devices
7.1.3 Neuroendoscopes
7.1.3.1 Stereotactic Systems
7.1.3.2 Aneurysm Clips
7.1.3.3 Others
7.1.4 Spinal Cord Stimulation Devices
7.1.4.1 Deep Brain Stimulation Devices
7.1.4.2 Sacral Nerve Stimulation Devices
7.1.5 Others
7.2 By Geography
7.2.1 North America
7.2.1.1 United States
7.2.1.2 Canada
7.2.1.3 Mexico
7.2.1.4 Rest of North America
7.2.2 Europe
7.2.2.1 France
7.2.2.2 Germany
7.2.2.3 United Kingdom
7.2.2.4 Italy
7.2.2.5 Spain
7.2.2.6 Rest of Europe
7.2.3 Asia-Pacific
7.2.3.1 China
7.2.3.2 Japan
7.2.3.3 India
7.2.3.4 Australia and New Zealand
7.2.3.5 South Korea
7.2.3.6 Rest of Asia-Pacific
7.2.4 Middle East & Africa
7.2.4.1 GCC
7.2.4.2 South Africa
7.2.4.3 Rest of the Middle East & Africa
7.2.5 South America
7.2.5.1 Brazil
7.2.5.2 Argentina
7.2.5.3 Rest of South America
8. Competitive Landscape
8.1 Mergers & Acquisition Analysis
8.2 Agreements, Collaborations, and Partnerships
8.3 New Products Launches
9. Key Players
9.1 B. Braun Melsungen AG
9.2 Boston Scientific
9.3 Stryker Corporation
9.4 Medtronic, Inc.
9.5 St. Jude Medical
9.6 Smith & Nephew
9.7 Sequent Medical
9.8 Nihon Kohden
9.9 List not Exhaustive
10. Future of the Market